Among those genes, ASXL1 and TP53 mutations have been associated with poor prognosis [45], whereas SF3B1 mutation in MDS patients with ringed sideroblasts has been associated with favorable prognosis [46]. This evidence concerns the gene TP53 and myelodysplastic syndrome.